• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » New nonprofit to seek consensus on social media

New nonprofit to seek consensus on social media

June 17, 2011
CenterWatch Staff

Frustrated by FDA inaction on guidance for digital marketing and social media, a host of industry players are banding together to form a nonprofit that can hammer out consensus on a way forward, according to Medical Marketing & Media.

The Digital Health Coalition is being convened by Mark Bard, formerly of Manhattan Research, and boasts some of the drug and digital health industries' biggest names on its advisory board. Among them are representatives from Merck, Roche, AstraZeneca, Lilly, Sanofi and GlaxoSmithKline, Google, Epocrates and HealthCentral, along with agencies Edelman and Digitas Health.

The aim, said Bard, is to get a conversation started.

“A lot of us have ideas about how the industry can evolve,” says Bard. “Let's start that conversation, with Google and Epocrates in the room and the coalition as a facilitator, and then work with DDMAC and from almost a liaison perspective say: ‘Hey, would you like to be a part of this conversation?'”

After a marathon two-day DDMAC public hearing on the topic in 2009, many drug marketers and medical agency execs were hopeful that the FDA would soon issue guidance that might narrow the regulatory gray areas in digital marketing. The agency first delayed and then scotched those hopes, pending further studies, by saying in late March, more or less: Don't hold your breath.

The industry has, to one extent or another, moved on, however cautiously, having accepted that little official clarity is forthcoming. The Digital Health Coalition's position, said Bard, is that it's not the government's job to tell industry how to market its products responsibly through digital channels. Rather, he said, “We fully intend to engage DDMAC and to come up with an industry consensus and say, ‘This is what we think makes sense.'”

The Digital Health Coalition will issue white papers and convene roundtables and webinars looking at three issues: mobile health, social media in health and search. An introductory webinar is scheduled for June 23 at 10 a.m. EST.

 

Enter Content Here

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing